Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide

BACKGROUND/AIM: Combining an anticancer agent fenretinide (HPR) or C6-pyridinium ceramide (LCL29) with Foscan-mediated photodynamic therapy (FoscanPDT) is expected to augment anticancer benefits of each substance. We showed that treatment with FoscanPDT+HPR enhanced accumulation of C16-dihydrocerami...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anticancer Res
Main Authors: Boppana, Nithin B., Kraveka, Jacqueline M., Rahmaniyan, Mehrdad, Li, Li, Bielawska, Alicja, Bielawski, Jacek, Pierce, Jason S., Delor, Jeremy S., Zhang, Kezhong, Korbelik, Mladen, Separovic, Duska
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066792/
https://ncbi.nlm.nih.gov/pubmed/28179290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/anticanres.11337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados